Literature DB >> 14641650

Digital electron microscopic examination of human sural nerve biopsies.

K A Sullivan1, M S Brown, L Harmon, D A Greene.   

Abstract

Diabetic peripheral polyneuropathy is characterized by axonal degeneration and regeneration as well as by Schwann cell and microvascular changes. These changes have been described at both the light (LM) and the electron microscopic (EM) levels; however, EM has not been applied to large clinical trials. Our goal was to adapt the rigorous techniques used for quantifying human biopsies with LM image analysis to accommodate ultrastructural analyses. We applied digital image capture and analysis to the ultrastructural examination of axons in sural nerve biopsies from diabetic patients enrolled in a multicenter clinical trial. The selection of sural nerve biopsies was based on the quality of specimen fixation, absence of physical distortion, and nerve fascicle size (> or =100,000; < or =425,000 microm2). Thin sections were collected on formvar-coated slot grids, stabilized with carbon and scanned on a Phillips CM100 transmission electron microscope. Digital images were captured with a Kodak Megaplus 1.6 camera. A montage was constructed using software derived from aerial mapping applications, and this virtual image was viewed by EM readers. Computer-assisted analyses included identification and labeling of individual axons and axons within regenerating clusters. The average density of regenerating myelinated axon clusters per mm2 was 65.8 +/- 5.1, range of 0-412 (n = 193). These techniques increase the number of samples that may be analyzed by EM and extend the use of this technique to clinical trials using tissue biopsies as a primary endpoint.

Entities:  

Mesh:

Year:  2003        PMID: 14641650     DOI: 10.1111/j.1085-9489.2003.03030.x

Source DB:  PubMed          Journal:  J Peripher Nerv Syst        ISSN: 1085-9489            Impact factor:   3.494


  4 in total

1.  The identification of gene expression profiles associated with progression of human diabetic neuropathy.

Authors:  Junguk Hur; Kelli A Sullivan; Manjusha Pande; Yu Hong; Anders A F Sima; Hosagrahar V Jagadish; Matthias Kretzler; Eva L Feldman
Journal:  Brain       Date:  2011-09-16       Impact factor: 13.501

Review 2.  Criteria for creating and assessing mouse models of diabetic neuropathy.

Authors:  Kelli A Sullivan; Stephen I Lentz; John L Roberts; Eva L Feldman
Journal:  Curr Drug Targets       Date:  2008-01       Impact factor: 3.465

3.  Decreased glycolytic and tricarboxylic acid cycle intermediates coincide with peripheral nervous system oxidative stress in a murine model of type 2 diabetes.

Authors:  Lucy M Hinder; Anuradha Vivekanandan-Giri; Lisa L McLean; Subramaniam Pennathur; Eva L Feldman
Journal:  J Endocrinol       Date:  2013-01-02       Impact factor: 4.286

4.  Identification of factors associated with sural nerve regeneration and degeneration in diabetic neuropathy.

Authors:  Junguk Hur; Kelli A Sullivan; Brian C Callaghan; Rodica Pop-Busui; Eva L Feldman
Journal:  Diabetes Care       Date:  2013-10-07       Impact factor: 19.112

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.